Ligand Pharmaceuticals

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.
Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. The Company's business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1987
Size (employees)
22 (est)
Website
ligand.com
Ligand Pharmaceuticals was founded in 1987 and is headquartered in San Diego, US

Key People/Management at Ligand Pharmaceuticals

John L. Higgins

John L. Higgins

CEO

Ligand Pharmaceuticals Office Locations

Ligand Pharmaceuticals has an office in San Diego
San Diego, US (HQ)
3911 Sorrento Valley Blvd

Ligand Pharmaceuticals Financials and Metrics

Ligand Pharmaceuticals Financials

Ligand Pharmaceuticals's revenue was reported to be $29.3 m in Q1, 2017
USD

Revenue (Q1, 2017)

29.3 m

Gross profit (Q1, 2017)

28.9 m

Gross profit margin (Q1, 2017), %

99%

Net income (Q1, 2017)

5.1 m

EBIT (Q1, 2017)

10.2 m

Market capitalization (20-Oct-2017)

3.3 b

Cash (31-Mar-2017)

10.6 m
Ligand Pharmaceuticals's current market capitalization is $3.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

49 m64.5 m71.9 m109 m

Revenue growth, %

32%11%52%

Cost of goods sold

5.6 m

Gross profit

103.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

10.6 m15 m14.6 m18.4 m17.7 m29.6 m19.5 m21.6 m29.3 m

Cost of goods sold

1.2 m1.5 m1.1 m955 k720 k999 k341 k

Gross profit

9.4 m13.5 m13.5 m28.7 m18.8 m20.6 m28.9 m

Gross profit Margin, %

89%90%93%97%96%95%99%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

11.6 m160.2 m97.4 m18.8 m

Accounts Receivable

2.2 m12.6 m6.2 m14.7 m

Inventories

1.4 m269 k1.6 m1.9 m

Current Assets

24.9 m185.2 m215.6 m163.1 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

14.5 m180.7 m165.8 m108.2 m93.8 m31.3 m61.4 m86.6 m10.6 m

Accounts Receivable

3.1 m5.8 m7.4 m5.5 m5.5 m11.8 m10 m6.6 m7.1 m

Inventories

817 k1.1 m2.8 m802 k1.2 m1.8 m3.8 m4 m7.6 m

Current Assets

28.6 m198.5 m191.7 m196.7 m210.3 m133.1 m126.6 m140.7 m174.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

11.4 m10.9 m254.9 m(1.6 m)

Depreciation and Amortization

2.7 m2.7 m2.6 m10.6 m

Accounts Receivable

2.4 m(10 m)6.5 m(8.5 m)

Inventories

646 k4.4 m(401 k)(244 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

1.3 m1.3 m754 k23.6 m224.5 m6.6 m(5.8 m)505.1 m

Depreciation and Amortization

2.5 m2.7 m2.7 m2.7 m

Accounts Receivable

3.1 m5.8 m7.4 m5.5 m5.5 m11.8 m10 m6.6 m7.1 m

Inventories

817 k1.1 m2.8 m802 k1.2 m1.8 m3.8 m4 m7.6 m
USDY, 2017

Revenue/Employee

1.3 m

Financial Leverage

1.7 x
Show all financial metrics

Ligand Pharmaceuticals Market Value History

Traffic Overview of Ligand Pharmaceuticals

Ligand Pharmaceuticals Online and Social Media Presence

Ligand Pharmaceuticals Company Life and Culture

You may also be interested in